Roche Recalls Potentially Faulty Heart Attack Test Tools

Law360, Chicago (April 24, 2012, 6:27 PM EDT) -- Roche Diagnostics Operations Inc. is recalling two lots of its Elecsys Troponin I heart attack diagnosis tools because they may yield inaccurate results that could be life-threatening, the U.S. Food and Drug Administration said Tuesday.

In a notice on its website, the FDA said Roche was recalling lot numbers 163176 and 163177 of its Elecsys Troponin I and Elecsys Troponin I STAT Immunoassays that were distributed from June 29 through Jan. 13.

The recall is categorized as Class 1, the most serious type of recall that...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.